bf/NASDAQ:VRDN_icon.jpeg

NASDAQ:VRDN

Viridian Therapeutics, Inc.

  • Stock

USD

Last Close

14.63

17/05 20:00

Market Cap

1.05B

Beta: 0.98

Volume Today

1.09M

Avg: 548.41K

PE Ratio

−3.84

PFCF: −5.44

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
263.09K
-
267.82K
1.80%
183K
31.67%
125.50K
31.42%
32K
74.50%
-3.31M
-
-3.31M
0%
average payables
218.48K
-
332.65K
52.26%
248.50K
25.30%
200.50K
19.32%
532.50K
165.59%
738.50K
38.69%
833.50K
12.86%
883K
5.94%
1.50M
69.82%
8.28M
452.28%
8.24M
0.54%
average receivables
1.09M
-
1.04M
4.91%
741K
28.82%
459K
38.06%
990K
115.69%
740K
25.25%
66K
91.08%
54K
18.18%
225.50K
317.59%
276.50K
22.62%
51K
81.56%
book value per share
161.59
-
597.55
269.79%
289.46
51.56%
-6.78
102.34%
30.02
542.82%
26.02
13.32%
7.54
71.02%
33.75
347.50%
15.75
53.33%
12.31
21.83%
0.01
99.92%
capex per share
-0.38
-
-26.53
6,876.84%
-3.42
87.11%
-0.06
98.18%
-0.19
207.39%
-0.23
17.61%
-0.04
82.17%
-0.01
70.63%
-0.03
140.18%
-0.02
12.41%
-0.00
99.92%
capex to depreciation
-0.03
-
-1.85
5,644.83%
-0.67
63.81%
-0.02
97.63%
-0.80
4,931.82%
-1.58
98.28%
-0.29
81.58%
-0.18
39.75%
-2.82
1,502.82%
-3.13
10.96%
0.08
102.57%
capex to operating cash flow
0.00
-
0.12
2,843.33%
0.02
85.17%
0.00
97.67%
0.01
2,005.09%
0.02
89.81%
0.00
85.95%
0.00
39.46%
0.01
339.07%
0.01
37.15%
0.00
42.59%
capex to revenue
-0.00
-
-0.06
5,473.15%
-0.05
21.29%
-0.00
98.14%
-0.06
6,735.72%
-0.05
13.65%
-0.02
64.52%
-0.04
112.43%
-0.11
185.18%
-0.45
294.28%
-2.86
535.85%
cash per share
16.69
-
510.57
2,958.59%
301.19
41.01%
69.47
76.94%
36.98
46.77%
31.66
14.37%
12.85
59.42%
35.88
179.25%
16.53
53.95%
13.23
19.94%
0.01
99.92%
days of inventory on hand
52.09
-
20.15
61.32%
27.61
37.05%
9.17
66.80%
days payables outstanding
59.93
-
28.70
52.11%
35.73
24.50%
22.78
36.26%
days sales outstanding
84.05
-
91.93
9.37%
56.66
38.36%
57.31
1.15%
132.76
131.63%
1.04
99.21%
8.84
745.93%
55.56
-
21.01
62.18%
debt to assets
0.19
-
0.01
94.79%
0.09
765.98%
0.25
186.49%
0.19
22.95%
0.16
17.65%
0.27
76.26%
0.00
98.74%
0.00
26.36%
0.01
373.42%
0.04
240.92%
debt to equity
0.34
-
0.01
96.12%
0.11
694.92%
-3.21
3,119.86%
0.26
108.04%
0.20
22.15%
0.53
162.80%
0.00
99.28%
0.00
26.92%
0.01
380.45%
0.05
243.45%
dividend yield
0.01
-
earnings yield
-0.08
-
-1.38
1,535.40%
-1.87
35.92%
-3.51
87.37%
-0.13
96.23%
-0.36
176.06%
-2.82
673.45%
-1.90
32.75%
-0.34
82.23%
-0.13
60.29%
-0.00
99.82%
enterprise value
26.14M
-
690.86K
97.36%
-3.67M
631.84%
1.32M
135.88%
163.20M
12,280.16%
67.38M
58.71%
-1.50M
102.23%
13.07M
971.19%
193.85M
1,383.00%
786.95M
305.95%
974.69B
123,757.05%
enterprise value over ebitda
-87.74
-
-0.10
99.88%
0.33
429.80%
-0.14
141.62%
-6.25
4,394.08%
-2.12
66.11%
0.04
101.73%
-0.32
986.13%
-2.44
654.61%
-6.08
148.77%
-3.83K
62,881.40%
ev to operating cash flow
-22.38
-
-0.31
98.61%
0.53
270.62%
-0.18
134.23%
-5.79
3,078.22%
-2.51
56.68%
0.04
101.66%
-0.44
1,154.82%
-3.55
709.12%
-8.39
136.12%
-5.29K
63,007.44%
ev to sales
6.06
-
0.16
97.36%
-1.45
1,005.26%
0.40
127.29%
40.77
10,220.41%
8.03
80.29%
-0.34
104.19%
12.45
3,801.30%
65.42
425.53%
444.10
578.80%
3.10M
698,864.00%
free cash flow per share
-93.50
-
-247.26
164.45%
-195.22
21.04%
-150.41
22.95%
-22.15
85.28%
-13.83
37.56%
-17.30
25.10%
-8.38
51.54%
-4.61
45.04%
-2.95
35.99%
-0.00
99.86%
free cash flow yield
-0.05
-
-0.43
846.40%
-1.16
168.11%
-2.00
72.55%
-0.14
92.93%
-0.30
114.94%
-2.40
689.68%
-0.51
78.79%
-0.23
54.27%
-0.10
56.68%
-0.00
99.81%
graham net net
-40.90
-
391.63
1,057.49%
242.71
38.02%
-17.03
107.02%
26.94
258.19%
24.17
10.28%
5.94
75.41%
32.73
450.61%
15.21
53.52%
11.88
21.89%
0.01
99.92%
graham number
791.27
-
3.25K
311.08%
1.43K
55.97%
200.48
86.00%
118.14
41.07%
98.50
16.62%
58.70
40.41%
153.92
162.23%
48.59
68.43%
32.91
32.27%
0.03
99.90%
income quality
0.54
-
0.28
48.13%
0.61
117.10%
0.57
6.31%
1.06
86.21%
0.82
22.74%
0.86
4.90%
0.27
68.76%
0.69
155.53%
0.72
5.13%
0.77
7.22%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
-0.10
-
-6.71
6,617.15%
-79.34
1,081.96%
-131.66
65.95%
-69.27
47.39%
-37.90
45.29%
-50.27
32.66%
-217.28
332.20%
-26.58K
12,131.03%
-276.35
98.96%
137.76
149.85%
interest debt per share
212.15
-
110.01
48.14%
34.65
68.51%
23.70
31.58%
8.03
66.11%
5.66
29.52%
4.37
22.72%
0.27
93.81%
0.04
83.79%
0.18
307.95%
0.00
99.77%
inventory turnover
7.01
-
18.12
158.56%
13.22
27.04%
39.81
201.17%
invested capital
0.34
-
0.01
96.12%
0.11
694.92%
-3.21
3,119.86%
0.26
108.04%
0.20
22.15%
0.53
162.80%
0.00
99.28%
0.00
26.92%
0.01
380.45%
0.05
243.45%
market cap
25.65M
-
5.73M
77.66%
6.05M
5.64%
3.61M
40.29%
200.72M
5,453.61%
89.69M
55.32%
15.04M
83.23%
58.51M
289.01%
235.63M
302.70%
937.27M
297.77%
974.77B
103,901.45%
net current asset value
408.42K
-
4.69M
1,047.58%
9.24M
97.18%
-326K
103.53%
37.90M
11,724.85%
50.57M
33.43%
15.23M
69.88%
118.39M
677.32%
184.17M
55.56%
384.52M
108.79%
438.08M
13.93%
net debt to ebitda
-1.64
-
0.74
145.11%
0.88
19.70%
0.24
72.62%
1.44
493.19%
0.70
51.19%
0.40
42.49%
1.13
179.42%
0.53
53.22%
1.16
120.49%
0.32
72.05%
net income per share
-172.21
-
-786.95
356.98%
-314.98
59.97%
-263.53
16.34%
-20.66
92.16%
-16.57
19.80%
-20.31
22.53%
-31.20
53.66%
-6.66
78.64%
-3.91
41.33%
-0.01
99.86%
operating cash flow per share
-93.12
-
-220.73
137.04%
-191.80
13.10%
-150.35
21.61%
-21.95
85.40%
-13.60
38.04%
-17.26
26.88%
-8.37
51.49%
-4.58
45.30%
-2.92
36.14%
-0.00
99.86%
payables turnover
6.09
-
12.72
108.81%
10.21
19.68%
16.03
56.88%
receivables turnover
4.34
-
3.97
8.56%
6.44
62.23%
6.37
1.14%
2.75
56.83%
349.42
12,609.23%
41.31
88.18%
6.57
-
17.37
164.43%
research and ddevelopement to revenue
0.02
-
0.07
202.29%
0.39
482.09%
0.27
32.60%
4.90
1,742.14%
3.63
26.00%
7.80
115.01%
26.96
245.61%
19.20
28.78%
56.94
196.57%
508.81
793.61%
return on tangible assets
-0.59
-
-0.98
65.87%
-0.88
9.99%
-2.98
238.93%
-0.51
83.02%
-0.49
2.13%
-1.40
183.53%
-0.85
39.68%
-0.39
53.89%
-0.29
26.04%
-0.48
68.13%
revenue per share
344.19
-
430.88
25.19%
70.57
83.62%
69.38
1.68%
3.12
95.50%
4.25
36.20%
2.14
49.75%
0.30
86.18%
0.25
15.78%
0.06
77.79%
0.00
99.99%
roe
-1.07
-
-1.32
23.58%
-1.09
17.37%
38.88
3,672.68%
-0.69
101.77%
-0.64
7.48%
-2.69
322.75%
-0.92
65.66%
-0.42
54.24%
-0.32
24.95%
-0.54
69.38%
roic
-0.14
-
-1.26
816.94%
-0.97
22.97%
-17.53
1,704.07%
-0.55
96.86%
-0.56
1.37%
-1.77
217.19%
-0.91
48.25%
-0.42
53.83%
-0.32
23.40%
-0.55
70.14%
sales general and administrative to revenue
0.41
-
1.63
293.05%
3.03
86.14%
2.37
21.83%
2.73
15.06%
1.32
51.67%
2.61
98.14%
12.63
383.92%
8.71
31.06%
19.85
127.97%
302.54
1,423.82%
shareholders equity per share
161.59
-
597.55
269.79%
289.46
51.56%
-6.78
102.34%
30.02
542.82%
26.02
13.32%
7.54
71.02%
33.75
347.50%
15.75
53.33%
12.31
21.83%
0.01
99.92%
stock based compensation to revenue
0.99
-
1.19
19.40%
0.63
46.75%
0.60
4.87%
0.44
27.10%
0.89
102.85%
3.47
290.08%
4.88
40.63%
11.15
128.48%
213.92
1,817.90%
tangible asset value
2.03M
-
5.99M
195.63%
10.41M
73.76%
-326K
103.13%
38.51M
11,912.88%
51.34M
33.33%
15.75M
69.32%
120.04M
661.95%
187.72M
56.38%
395.06M
110.46%
442.02M
11.89%
tangible book value per share
161.59
-
597.55
269.79%
289.46
51.56%
-6.78
102.34%
30.02
542.82%
26.02
13.32%
7.54
71.02%
33.75
347.50%
15.75
53.33%
12.31
21.83%
0.01
99.92%
working capital
667.77K
-
4.80M
618.21%
9.27M
93.20%
-326K
103.52%
47.97M
14,815.03%
58.64M
22.23%
19.56M
66.64%
118.94M
508.09%
186.53M
56.83%
391.20M
109.73%
459.84M
17.55%

All numbers in USD (except ratios and percentages)